Literature DB >> 21035070

Thyroid eye disease: honing your skills to improve outcomes.

Linda R Dagi1, Alexandra T Elliott, Gill Roper-Hall, Oscar A Cruz.   

Abstract

Thyroid eye disease affects the eyelids, orbital compartment, and extraocular muscles, resulting in a highly variable degree of chemosis and enlargement of the preorbital fat pads, eyelid retraction, proptosis, restrictive strabismus, torticollis, and, rarely, compressive or congestive optic neuropathy. Although most patients with thyroid eye disease are best treated conservatively, those more severely affected may benefit from orbital decompression, strabismus surgery, or eyelid retraction repair after stabilization has occurred. Botulinum A toxin, high-dose intravenous corticosteroids, and radiation treatment are therapeutic options in select cases. Compressive or congestive optic neuropathy and severe corneal exposure warrant consideration of surgical intervention on an urgent basis without waiting for stabilization. Epidemiology and risks and benefits of high-dose steroids and radiation therapy are reviewed along with recommendations to improve conservative as well as surgical management of this disease. Strategies to manage strabismus and optimize outcomes are provided.
Copyright © 2010 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21035070     DOI: 10.1016/j.jaapos.2010.07.005

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  5 in total

1.  Chemodenervation of extraocular muscles with botulinum toxin in thyroid eye disease.

Authors:  David B Granet; Nickisa Hodgson; Kyle J Godfrey; Ricardo Ventura; Don O Kikkawa; Leah Levi; Michael Kinori
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-02-10       Impact factor: 3.117

2.  Corneal biomechanical changes and intraocular pressure in patients with thyroid orbitopathy.

Authors:  Zofia Pniakowska; Anna Klysik; Roman Gos; Piotr Jurowski
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

3.  Presence of thyroid-associated ophthalmopathy in Hashimoto's thyroiditis.

Authors:  Emrah Kan; Elif Kilic Kan; Gülcin Ecemis; Ramis Colak
Journal:  Int J Ophthalmol       Date:  2014-08-18       Impact factor: 1.779

4.  The management of large-angle esotropia in Graves ophthalmopathy with combined medial rectus recession and lateral rectus resection.

Authors:  James A Garrity; Daniel A Greninger; Noha S Ekdawi; Eric A Steele
Journal:  J AAPOS       Date:  2019-01-19       Impact factor: 1.220

Review 5.  Management of Thyroid Eye Disease-Related Strabismus.

Authors:  Mohammad Reza Akbari; Arash Mirmohammadsadeghi; Raziyeh Mahmoudzadeh; Amirreza Veisi
Journal:  J Curr Ophthalmol       Date:  2020-03-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.